Kevin Anderson
Sr. Director, Clinical Operations at AlloVir, an ElevateBio Company - Waltham, Massachusetts, US
Kevin Anderson's Colleagues at AlloVir, an ElevateBio Company
Jessica Chinault-Jalboot
Head of Quality and Compliance, GCP/GVP and Regulatory
Kevin Anderson's Contact Details
(936) 662-3626
316 Huntington Avenue,Boston,Massachusetts,02115,United States
AlloVir, an ElevateBio Company
Kevin Anderson's Company Details
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVir’s technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.